Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in pediatric patients

Dr. Jane Young contributes to peer-reviewed case study that follows the treatment of two autoimmune dysautonomia patients. Houston-based biotechnology company Celltex Therapeutics Corporation announces that Stem Cells and Development has published “Autologous Adipose Stem Cell Therapy for Autonomic Nervous System … read more »

March 13th, 2017

Houston regenerative medicine leaders host delegation from Mexico

A blue ribbon delegation, composed of representatives from the offices of the Secretary of Health of Mexico, the Commission for the Protection against Sanitary Risk (COFEPRIS) — the equivalent of the U.S. FDA in Mexico — and The National Institute … read more »

March 10th, 2017

Celltex client Sarah Hughes attends joint address to Congress as honored guest

Celltex client Sarah Hughes has inspired many across the country after experiencing major improvements in her quality of life since receiving high-dose, adult mesenchumal stem cell therapy for severe systemic juvenile idiopathic arthritis (SJIA) and dysautonomia. Following a public appearance … read more »

February 28th, 2017

Stem cells collected from fat may have use in anti-aging treatments

Researchers at the University of Pennsylvania School of Medicine have found that adult stem cells collected directly from human fat have the potential for use in anti-aging treatments. While developing a new model to study the chronological aging of cells, … read more »

February 17th, 2017

Guest Blog: Mikaela Aschoff is looking forward to a healthy future

I was diagnosed with Dysautonomia after collapsing at my freshman homecoming dance on October 23, 2010 and since then my life has completely changed from the normality I once knew. My days have been filled with fainting episodes, seizures, migraines, … read more »

February 14th, 2017

Incoming Energy Secretary Rick Perry resigns from Celltex Therapeutics Board of Directors

Former Texas Governor and incoming Secretary of the U.S. Department of Energy, Rick Perry, has resigned from the board of directors of Houston-based biotechnology company, Celltex Therapeutics Corporation, as is customary of an individual serving on the U.S. Cabinet. “On … read more »

February 6th, 2017

First-of-its-kind study explores whether stem cells might lessen inflammation in CF patients

A team of researchers at University Hospital’s Rainbow Babies & Children’s Hospitals are conducting the first ever stem cell trial for cystic fibrosis (CF). Researchers will follow trial participants who receive a single infusion of human mesenchymal stem cells for … read more »

February 2nd, 2017

U.S. Congressman Pete Olson visits Celltex lab

Celltex proudly welcomed U.S. Congressman Pete Olson, representative of the 22nd District of Texas, to its offices in Houston, Texas. Celltex staff members were on hand to greet Congressman Olson and provide him with a tour of the Celltex lab … read more »

January 6th, 2017

Texas Congressman Pete Olson dedicates vote for 21st Century Cures Act in honor of Celltex client Sarah Hughes

The U.S. House of Representatives overwhelmingly passed the 21st Century Cures Act on Wednesday, November 30. The bill, which had widespread bipartisan support, will work to promote medical innovation, speed, and access to new drugs and will provide a breakthrough … read more »

December 5th, 2016

Celltex Client Shares Stem Cell Journey with Congressman Pete Olson

Houston resident and Celltex client, Sarah Hughes, shared her inspiring adult stem cell journey with Congressman Pete Olson on Wednesday, October 5, 2016. Olson, who represents the 22nd district of Texas, is a major supporter of the 21st Century Cures Act and … read more »

November 3rd, 2016